GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: A$3.95 M
• Last 3 months FTD volume: A$61.56 M
• Last 12 months FTD volume: A$0.39 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
AstraZeneca AZN	A$28.29 M	A$0.10 B	🇬🇧 UK
Pfizer PFE	A$29.26 M	A$0.10 B	🇺🇸 USA
Merck MRK	A$17.08 M	A$0.16 B	🇺🇸 USA
Novartis NVS	A$19.76 M	A$75.6 M	🇨🇭 Switzerland
Sanofi SNY	A$9.04 M	A$67.5 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	A$3.35 M	A$38.2 M	🇮🇱 Israel
Dynavax Technologies DVAX	A$0.47 M	A$1.61 M	🇺🇸 USA